ACM
CERE

ADAR1 Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-93,350
Closed -$3.82M 332
2024
Q2
$3.82M Buy
93,350
+69,091
+285% +$2.83M 0.72% 23
2024
Q1
$1.03M Sell
24,259
-86,441
-78% -$3.65M 0.23% 55
2023
Q4
$4.69M Buy
+110,700
New +$4.69M 1.68% 13